Second, while these increases are seemingly not disease-specific, we demonstrate that plasma NfL is clinically useful in differentiating atypical parkinsonian disorders from PD, in identifying dementia in Down Syndrome, distinguishing neurodegenerative disorders from depression in older adults and, potentially, identifying frontotemporal dementia in patients with cognitive impairment. Here, NEFL is linked to dementia.